Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ellman

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Bulletin on the Rheumatic Diseases|January 1, 1976
The 1976 annual meeting of the American Rheumatism AssociationF R Schmid, W J Arnold, J S Davis, et al.
Journal of Clinical Apheresis|December 28, 1999
Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapyR Flamholz, T Tran, G I Grad, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
The Journal of Rheumatology|February 15, 2007
Outcome measurements in scleroderma: results from a delphi exerciseHashim Gazi, Janet E Pope, Philip Clements, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Bulletin on the Rheumatic Diseases|January 1, 1976
The 1976 annual meeting of the American Rheumatism AssociationF R Schmid, W J Arnold, J S Davis, et al.
Journal of Clinical Apheresis|December 28, 1999
Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapyR Flamholz, T Tran, G I Grad, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
The Journal of Rheumatology|February 15, 2007
Outcome measurements in scleroderma: results from a delphi exerciseHashim Gazi, Janet E Pope, Philip Clements, et al.
Pageof 8